Connecticut Governor Signs Psychedelic Reform Deal
Connecticut has become the newest state to consider reform proposals regarding psychedelic medicines.
psilocybin
Cybin Launches First Clinical Trial to Treat Frontline Workers Experiencing COVID-Related Distress With Psychedelics
A new first-of-its-kind psychedelic study will treat frontline workers experiencing distress related to COVID with psilocybin.
Biotech Firm PsyBio Therapeutics Is Producing Psilocybin From Bacteria
PsyBio Therapeutics is harvesting the psychedelic compound psilocybin from a strain of bacteria instead of mushrooms.
How a Psilocybin Retreat Changed Everything I Knew About Psychedelics
Here’s how a legal psilocybin truffle retreat in the Netherlands changed this author’s relationship with psychedelics.
Attorneys General, Organizations, Specialists Sue DEA for Access to Psilocybin for Terminally Ill Patients
A coalition of activists, organizations, and attorneys general are suing the DEA on behalf of terminally ill patients seeking psilocybin treatment.
Actress Kristen Bell Used Psychedelic Mushrooms to Treat Depression
Actress Kristen Bell says psychedelic mushrooms have helped her to treat her depression and anxiety symptoms.
Could Psychedelics Cure Color Blindness? New Data Sees a Bright Future
Could psychedelics help people suffering from color blindness? New research sees great potential with lsd and psilocybin.
Wake Receives First-Ever Approval for Psilocybin Microdose Study for Anxiety and Depression
In the first approval of its kind, Wake Network will study the effects of microdosing psilocybin on anxiety and depression.
Canada Approves New Leaf’s Bid to Build First-Of-Its-Kind Psilocybin Lab
New Leaf Canada has received permission from Health Canada to build a first-of-its-kind laboratory to produce and study psilocybin and psilocin.
Maine Bill Seeks to Legalize Therapeutic Use of Psilocybin
Maine could soon become the second U.S. state to legalize the use of medicinal psilocybin for therapeutic use.
End of content
End of content